Christine Tkaczyk

Company: AstraZeneca

Job title: director

Seminars:

Leveraging Identity Assays to Enhance Drug Substance Stability to Preserve Integrity & Extend Usability Across Development Stages 11:00 am

Incorporating computational modelling to predict sequence based degradation and guide rational design of mRNA Drug Substance to prevent late-stage instability Modifying mRNA sequence elements, such as UTRs and secondary structures, to improve inherent drug substance stability during storage and handling Leveraging identity assays to confirm transcript and mRNA length integrity and detect degradation over time…Read more

day: Conference Day Two - Track 1 - AM